Page 2 - Thomas Jefferson University

Medications

New drug target to treat pain from visceral organs

An approved drug for chronic constipation also relieves the pain associated with that condition. New research by Scott Waldman, MD, Ph.D., chair of pharmacology, physiology and cancer biology at Jefferson, demonstrates that ...

Oncology & Cancer

Neuronal molecule makes prostate cancer more aggressive

Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer to progress into a highly ...

Medical research

A way to make asthma drugs last longer

For many, inhalers are a sort of miracle drug. From gasping for air one minute, to breathing normally the next, patients can experience significant relief after one or two puffs. What few people realize is that these life-saving ...

Oncology & Cancer

Stress granules may drive obesity-associated pancreatic cancer

Obesity is a known risk factor for at least 13 types of cancer, in part because it creates ever-present inflammatory state. For years, one researcher has wondered if there's more to the story than inflammation. New research ...

Oncology & Cancer

The obesity paradox in lung cancer diagnosis may differ by race

Lung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates simultaneously rising, researchers have investigated the connections between cancer risk and body mass index ...

Oncology & Cancer

New lung-cancer screening guidelines reduce disparity

In 2013, the US Preventive Task Force (USPSTF) published guidelines that recommended individuals at high risk for developing lung cancer who met the eligibility criteria, undergo annual lung screening by low-dose CT scan. ...

page 2 from 40